A research warns that Human Papillomavirus, a sexually transmitted disease, might cause bladder cancerSeptember 26, 2007The Human Papillomavirus (HPV) is considered the cause of one of the most important sexually transmitted diseases nowadays, and affects both men and women. HPV is so common in our society that only people who have never had sexual relations can be sure that they have not been exposed to this disease. However, as with other microbes, people infected do not necessarily develop the disease, because, in most cases, it only means the colonization. Only some of the people colonized will fall ill with different processes. Nevertheless, the development of this disease might have serious consequences: It is probable that HPV is related to bladder cancer, according to a recent study carried out by the Department of Microbiology of the University of Granada, in collaboration with the Department of Biostatistics and the Urology Service of San Cecilio Hospital. Several previous studies point out the possibility that HPV might cause, in certain subjects, some types of cancer: cervical, anus, vulva, penis, oropharyngeal (the middle part of the throat behind the mouth including the back of the tongue, the soft palate, the side and back walls of the throat) and bladder cancer. The researchers from Granada have focused their study on bladder cancer and have found some evidence of the relationship between both diseases. Nevertheless, they warn that further research on this matter is needed, particularly in order rule out the assumption that this infection is only a viral colonization and does not cause cancer (that is to say, the tumor appeared before the tissue was infected by the virus).
Jose Gutiérrez Fernández, lecturer responsible for this study explains that, in order to draw this preliminary conclusion, 44 articles related to this matter written by experts from all around the world were analysed. "Our work consisted in a bibliographic review of the observational case studies published up to July 2005, in order to establish the degree of relationship found between bladder cancer and HPV infection". Standardization of methods The study carried out at the UGR points out that the relationship between these two diseases depends on the method used: these scientists found different results depending on whether the research was based on the person's DNA or not. "Of the 44 studies reviewed, in 39 the presence of DNA was studied. In the other 7 studies the HPV infection was studied through antigen or antibody detection". The great majority of these studies use PCR (Polymerase Chain Reaction) for the analysis. With this technique it is possible to duplicate as many times as desired a fragment of DNA in a test tube, and millions of identical molecules can be created from a single DNA molecule. The relationship between HPV and bladder cancer might be due to the fact that the microorganism which generates the infection has DNA. Therefore, it acts directly on the cell nucleus and makes the cell cancerous. Moreover, the infection spreads quickly when healthy mucus comes into contact with infected mucus. The research performed by the UGR points out that there might be a relationship between Human Papillomavirus infection and the appearance of the tumor. However, Gutiérrez Fernández warns that "in order to draw a final conclusion, it is necessary to carry out a study with a sufficient number of cases and samples in which a combination of several microbiological techniques is applied to the same subject and sample". University of Granada | |||||||||||||||||||||
|
Related HPV Current Events and HPV News Articles Survival of head and neck cancer patients is greatly affected by coexisting ailments Current estimates for head and neck cancer survival are largely inaccurate because they widely disregard many of the most common diseases such patients have in addition to their primary cancer, says Jay Piccirillo, M.D., a head and neck specialist at Washington University School of Medicine in St. Louis, the Siteman Cancer Center and Barnes-Jewish Hospital. LSUHSC public health contributes to estimate of HPV-related cancers Professor Vivien Chen, PhD,. Associate Professor Xiao Cheng Wu, MD, PhD and Assistant Professor Edward Peters, DMD, SM, ScD, at LSU Health Sciences Center New Orleans School of Public Health contributed five papers to the largest most comprehensive assessment of the burden of human papillomavirus (HPV)-associated cancers in the United States to date. Oral rinses used for tracking HPV-positive head and neck cancers holds promise for cancer screening A study published in the journal Clinical Cancer Research, a journal of the American Association for Cancer Research, validates a non-invasive screening method with future potential for detection of human papillomavirus (HPV)-positive head and neck cancers. Extra copies of EGFR gene signal poor prognosis for vulvar cancer A genetic fingerprint identified in patients with a gynecologic cancer may reveal candidates for targeted therapy. Model highlights benefits and risks of cervical cancer screening methods In an analysis based on a computer model, it appears that comparing the benefits and risks of different cervical cancer prevention approaches may help women and their physicians choose appropriate screening strategies. New HPV test for developing countries shows high accuracy in predicting cervical disease: Study A new HPV test developed by QIAGEN specifically for use in regions of the world with scarce resources is "substantially" more accurate in identifying women with cervical disease than the current methods (Pap testing and visual inspection) in these countries. Higher anaphylaxis rates after HPV vaccination: CMAJ study The estimated rate of anaphylaxis in young women after human papillomavirus (HPV) vaccination was significantly higher - 5 to 20 fold - than that identified in comparable school-based vaccination programs. Cervical cancer prevention should focus on vaccinating adolescent girls The cost-effectiveness of vaccination in the United States against human papillomavirus (HPV), a sexually-transmitted virus that causes cervical cancer, will be optimized by achieving universal vaccine coverage in young adolescent girls, by targeting initial "catch-up" efforts to vaccinate women younger than 21 years of age, and by revising current screening policies. NIST trumps the clumps: Making biologic drugs safer Scientists at the National Institute of Standards and Technology (NIST) have developed a technique to measure the formation of clumps of proteins in protein-based pharmaceuticals. New study shows potential to treat or prevent viral cancers A new study, presented at the SNM 55th Annual Meeting, shows that radioimmunotherapy (RIT) targeting viral antigens offers a novel option to treat-or even prevent-many viral cancers by targeting cancer cells expressing viral antigens or infected cells before they convert into malignancy. More HPV Current Events and HPV News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||